| CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells S Sivori, M Falco, MD Chiesa, S Carlomagno, M Vitale, L Moretta, ... Proceedings of the National Academy of Sciences 101 (27), 10116-10121, 2004 | 582 | 2004 |
| NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor M Vitale, MD Chiesa, S Carlomagno, D Pende, M Arico, L Moretta, ... Blood 106 (2), 566-571, 2005 | 485 | 2005 |
| The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function MD Chiesa, S Carlomagno, G Frumento, M Balsamo, C Cantoni, R Conte, ... Blood 108 (13), 4118-4125, 2006 | 422 | 2006 |
| The natural killer cell‐mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig‐like receptors MD Chiesa, M Vitale, S Carlomagno, G Ferlazzo, L Moretta, A Moretta European journal of immunology 33 (6), 1657-1666, 2003 | 343 | 2003 |
| The small subset of CD56brightCD16– natural killer cells is selectively responsible for both cell proliferation and interferon‐γ production upon interaction with … M Vitale, MD Chiesa, S Carlomagno, C Romagnani, A Thiel, L Moretta, ... European journal of immunology 34 (6), 1715-1722, 2004 | 230 | 2004 |
| Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes R Zambello, M Falco, MD Chiesa, L Trentin, D Carollo, R Castriconi, ... Blood 102 (5), 1797-1805, 2003 | 141 | 2003 |
| Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT S Sivori, S Carlomagno, M Falco, E Romeo, L Moretta, A Moretta Blood, The Journal of the American Society of Hematology 117 (16), 4284-4292, 2011 | 135 | 2011 |
| Features of memory-like and PD-1+ human NK cell subsets M Della Chiesa, S Pesce, L Muccio, S Carlomagno, S Sivori, A Moretta, ... Frontiers in immunology 7, 217681, 2016 | 129 | 2016 |
| A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 S Sivori, M Falco, S Carlomagno, E Romeo, C Soldani, A Bensussan, ... Blood, The Journal of the American Society of Hematology 116 (10), 1637-1647, 2010 | 108 | 2010 |
| TLR/NCR/KIR: which one to use and when? S Sivori, S Carlomagno, S Pesce, A Moretta, M Vitale, E Marcenaro Frontiers in Immunology 5, 83145, 2014 | 100 | 2014 |
| Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells S Sivori, S Carlomagno, L Moretta, A Moretta European journal of immunology 36 (4), 961-967, 2006 | 95 | 2006 |
| Human NK cell response to pathogens M Della Chiesa, E Marcenaro, S Sivori, S Carlomagno, S Pesce, ... Seminars in immunology 26 (2), 152-160, 2014 | 88 | 2014 |
| Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia C Quintarelli, S Sivori, S Caruso, S Carlomagno, M Falco, I Boffa, ... Leukemia 34 (4), 1102-1115, 2020 | 71 | 2020 |
| Activating KIRs and NKG2C in viral infections: toward NK cell memory? M Della Chiesa, S Sivori, S Carlomagno, L Moretta, A Moretta Frontiers in immunology 6, 162671, 2015 | 69 | 2015 |
| Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer S Sivori, M Della Chiesa, S Carlomagno, L Quatrini, E Munari, P Vacca, ... Frontiers in immunology 11, 576503, 2020 | 67 | 2020 |
| NK cell-based immunotherapy for hematological malignancies S Sivori, R Meazza, C Quintarelli, S Carlomagno, M Della Chiesa, ... Journal of Clinical Medicine 8 (10), 1702, 2019 | 67 | 2019 |
| An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more M Vitale, C Cantoni, M Della Chiesa, G Ferlazzo, S Carlomagno, D Pende, ... Frontiers in Immunology 10, 465770, 2019 | 67 | 2019 |
| NK/DC crosstalk in anti-viral response E Marcenaro, S Carlomagno, S Pesce, A Moretta, S Sivori Current Topics in Innate Immunity II, 295-308, 2012 | 57 | 2012 |
| KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts E Marcenaro, S Pesce, S Sivori, S Carlomagno, L Moretta, A Moretta Blood, The Journal of the American Society of Hematology 121 (17), 3396-3401, 2013 | 49 | 2013 |
| Bridging innate NK cell functions with adaptive immunity E Marcenaro, S Carlomagno, S Pesce, A Moretta, S Sivori Crossroads between Innate and Adaptive Immunity III, 45-55, 2011 | 48 | 2011 |
